These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 16165012

  • 1. Chemokines in myocardial ischemia.
    Frangogiannis NG, Entman ML.
    Trends Cardiovasc Med; 2005 Jul; 15(5):163-9. PubMed ID: 16165012
    [Abstract] [Full Text] [Related]

  • 2. CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts.
    Dewald O, Zymek P, Winkelmann K, Koerting A, Ren G, Abou-Khamis T, Michael LH, Rollins BJ, Entman ML, Frangogiannis NG.
    Circ Res; 2005 Apr 29; 96(8):881-9. PubMed ID: 15774854
    [Abstract] [Full Text] [Related]

  • 3. The role of the chemokines in myocardial ischemia and reperfusion.
    Frangogiannis NG.
    Curr Vasc Pharmacol; 2004 Apr 29; 2(2):163-74. PubMed ID: 15320517
    [Abstract] [Full Text] [Related]

  • 4. Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy.
    Frangogiannis NG, Dewald O, Xia Y, Ren G, Haudek S, Leucker T, Kraemer D, Taffet G, Rollins BJ, Entman ML.
    Circulation; 2007 Feb 06; 115(5):584-92. PubMed ID: 17283277
    [Abstract] [Full Text] [Related]

  • 5. Chemokines in the ischemic myocardium: from inflammation to fibrosis.
    Frangogiannis NG.
    Inflamm Res; 2004 Nov 06; 53(11):585-95. PubMed ID: 15693606
    [Abstract] [Full Text] [Related]

  • 6. Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts.
    Frangogiannis NG, Ren G, Dewald O, Zymek P, Haudek S, Koerting A, Winkelmann K, Michael LH, Lawler J, Entman ML.
    Circulation; 2005 Jun 07; 111(22):2935-42. PubMed ID: 15927970
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy.
    Göser S, Ottl R, Brodner A, Dengler TJ, Torzewski J, Egashira K, Rose NR, Katus HA, Kaya Z.
    Circulation; 2005 Nov 29; 112(22):3400-7. PubMed ID: 16316965
    [Abstract] [Full Text] [Related]

  • 11. MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy.
    Xia Y, Frangogiannis NG.
    Inflamm Allergy Drug Targets; 2007 Jun 29; 6(2):101-7. PubMed ID: 17692033
    [Abstract] [Full Text] [Related]

  • 12. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction.
    Morimoto H, Takahashi M, Izawa A, Ise H, Hongo M, Kolattukudy PE, Ikeda U.
    Circ Res; 2006 Oct 13; 99(8):891-9. PubMed ID: 16990567
    [Abstract] [Full Text] [Related]

  • 13. Antagonist of interferon-inducible protein 10/CXCL10 ameliorates the progression of autoimmune sialadenitis in MRL/lpr mice.
    Hasegawa H, Inoue A, Kohno M, Muraoka M, Miyazaki T, Terada M, Nakayama T, Yoshie O, Nose M, Yasukawa M.
    Arthritis Rheum; 2006 Apr 13; 54(4):1174-83. PubMed ID: 16575871
    [Abstract] [Full Text] [Related]

  • 14. Compartment-specific expression and function of the chemokine IP-10/CXCL10 in a model of renal endothelial microvascular injury.
    Panzer U, Steinmetz OM, Reinking RR, Meyer TN, Fehr S, Schneider A, Zahner G, Wolf G, Helmchen U, Schaerli P, Stahl RA, Thaiss F.
    J Am Soc Nephrol; 2006 Feb 13; 17(2):454-64. PubMed ID: 16382019
    [Abstract] [Full Text] [Related]

  • 15. Mast cell tryptase may modulate endothelial cell phenotype in healing myocardial infarcts.
    Somasundaram P, Ren G, Nagar H, Kraemer D, Mendoza L, Michael LH, Caughey GH, Entman ML, Frangogiannis NG.
    J Pathol; 2005 Jan 13; 205(1):102-11. PubMed ID: 15586361
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Targeting the chemokines in cardiac repair.
    Cavalera M, Frangogiannis NG.
    Curr Pharm Des; 2014 Jan 13; 20(12):1971-9. PubMed ID: 23844733
    [Abstract] [Full Text] [Related]

  • 18. CXCR2 blockade impairs angiotensin II-induced CC chemokine synthesis and mononuclear leukocyte infiltration.
    Abu Nabah YN, Losada M, Estellés R, Mateo T, Company C, Piqueras L, Lopez-Gines C, Sarau H, Cortijo J, Morcillo EJ, Jose PJ, Sanz MJ.
    Arterioscler Thromb Vasc Biol; 2007 Nov 13; 27(11):2370-6. PubMed ID: 17717298
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.